STOCK TITAN
  1. Home
  2. PALX

Palomino Labs (PALX) Stock Price, News & Analysis

PALX OTC
Published by Stock Titan Data refreshed

What Changed

Price Move History

Daily moves over 5%
16 65 sessions, July 10, 2026 to November 2, 2026
Largest daily move
+30.3% close of July 22, 2026
1-month change
-17.2% closing prices, September 30, 2026 to November 2, 2026

Company Description

PALX has declined 17.2% over the past month. The last closing price was $14.00.

For FY2025, Palomino Labs reported net income of -$3.2M and diluted earnings per share of -$0.47.

This page collects what Stock Titan holds for PALX, including price data, latest news, SEC filings, financial highlights, and short interest trends.

Stock Performance

Chart
$14.00
-1.41%
-0.20
Last updated: November 2, 2026 at 16:00
-17.2%
Performance 1 month
-
Market Cap
-
Shares outstanding

Palomino Labs (PALX) closed at $14.00 on November 2, 2026. Over the past month, the price has lost 17.2%.

See what a $1,000 investment in PALX would be worth today

Average down calculator for PALX

PALX Metrics & Rankings

Piotroski F-Score
2/6 Partial
#6,621
Month to date
-1.4%
View ranking

Price returns through November 2, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

View All
0.00%

Palomino Laboratories Inc. Receives Its First Commercial Purchase Order from a Hyperscaler Customer For GaN MicroLED Communication Chips Supporting AI Optical Interconnects

AI
+3.65%

Palomino Laboratories Co-Founder Steven DenBaars to Present at MicroLED Connect 2026

+0.98%

Palomino Laboratories to Participate in the 7th Annual Needham Virtual Semiconductor & SemiCap Conference on August 20, 2026

+0.33%

Palomino Laboratories Inc. Introduces New Digital Experience for Customers and Partners

+2.33%

Palomino Laboratories Completes Vega Links Acquisition and Strengthens Technology Leadership to Accelerate Next-Generation AI Interconnect Development

acquisition AI
+30.33%

Palomino Laboratories Inc. Ships First Generation MicroLED Light Engine Prototypes to First Hyperscaler Customer

+24.58%

Palomino Laboratories Announces Binding LOI to Acquire Vega Links Inc. to Create a Next-Generation AI Interconnect Company

acquisition AI
+8.02%

Palomino Laboratories Common Stock Commences Trading on the OTCQB VENTURE MARKET

—

Palomino Laboratories Inc. Co-Founder, Dr. Steven P. DenBaars, Receives the Prestigious 2026 IEEE Nick Holonyak Jr. Award at IEEE 2026 Honors Ceremony

—

Palomino Laboratories Inc. Closes $15 Million at $4/share

Palomino Labs has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 0 with negative movement. Key topics include AI, acquisition. View all PALX news →

SEC Filings

View All

[8-K/A] With $0 in illustrative combined revenue, Palomino (PALX) adds acquisition loss figures.

[DEF 14A] Directors and executives own 30.3% as Palomino Laboratories (PALX) puts its stock plan reserve to a vote.

[PRE 14A] A stock-award plan tied to 15% of shares has a proposed floor at Palomino Laboratories (PALX).

[SCHEDULE 13D/A] Palomino Laboratories (PALX) director now controls nearly 1.9M shares

[8-K] Palomino Laboratories (PALX) buys Vega Links, boosting AI interconnect reach

[10-Q] Palomino Labs (PALX) raises $16,975,412 and plans Vega Links acquisition

[4] Palomino Laboratories (PALX) director gains 120,000 shares in Vega Links stock swap

[8-K] Palomino Laboratories (OTCQB: PALX) plans all-stock Vega Links acquisition

[10-Q] Palomino Laboratories (PALX) posts Q1 2026 loss and raises $16.98M in private placement

[8-K] Accredited investors add $1.88M to Palomino Laboratories (PALX)

Palomino Labs has filed 10 recent SEC filings, including 3 Form 8-K, 2 Form 10-Q, 1 Form 4, 1 Form 8-K/A. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all PALX SEC filings →

Financial Highlights

View Full Financials

Palomino Labs reported operating income of -$2.7M in FY2025, and net income was -$3.2M. Diluted earnings per share stood at -$0.47. The company generated -$1.3M in operating cash flow. The current ratio was 25.07, measuring current assets divided by current liabilities.

-$3.2M
Net Income (FY2025)
-$0.47
Diluted EPS (FY2025)
-$1.3M
Operating Cash Flow
25.07
Current Ratio
-$2.7M
Operating Income
—
Revenue (FY2025)

Upcoming Events

No upcoming events scheduled for PALX.

Short Interest History

Last 12 Months

Short interest in Palomino Labs (PALX) currently stands at 13 shares, down 95.7% from the previous reporting period, representing 0.0% of the float. Since August 2026, short interest has decreased by 91.2%.

Days to Cover History

Last 12 Months

Days to cover for Palomino Labs (PALX) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.

Frequently Asked Questions

The current quoted price of Palomino Labs (PALX) is $14.00 as of November 2, 2026.

The FY2025 net income of Palomino Labs (PALX) is -$3.2M, from its most recent completed fiscal year.

The diluted earnings per share (EPS) of Palomino Labs (PALX) is -$0.47 for FY2025, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of Palomino Labs (PALX) is -$1.3M for FY2025, its most recent completed fiscal year. Learn about cash flow.

The current ratio of Palomino Labs (PALX), current assets divided by current liabilities, was 25.07 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

The operating income of Palomino Labs (PALX) is -$2.7M for FY2025, its most recent completed fiscal year. Learn about operating income.